6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats

Brain Research

Volumn 1477, Issue , 2012, Pages 59-73

  Kolasiewicz, Wacław ^a   Kuter, Katarzyna ^a   Berghauzen, Klemencja ^a   Nowak, Przemysław ^b   Schulze, Gert ^c   Ossowska, Krystyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cerebellum; Harmaline; Retrorubral field; Substantia nigra pars compacta; Tremor

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DESIPRAMINE; DOPAMINE; HARMALINE; NORADRENALIN; OXIDOPAMINE; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN DAMAGE; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; EVOKED MUSCLE RESPONSE; FORELIMB; HEAD; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROMODULATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RAT; RETRORUBRAL FIELD; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; STEREOLOGY; SUBSTANTIA NIGRA PARS COMPACTA; SYMPTOM; TREMOR; TRUNK;

3,4-DIHYDROXYPHENYLACETIC ACID; ADRENERGIC AGENTS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBELLUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINERGIC NEURONS; HARMALINE; HYDROXYINDOLEACETIC ACID; MALE; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, WISTAR; SEROTONIN; STATISTICS, NONPARAMETRIC; SUBSTANTIA NIGRA; TREMOR; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS;

EID: 84866351720     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.08.015     Document Type: Article

References (51)

1. M. Arshaduddin, S. Al Kadasah, N. Biary, S. Al Deeb, K. Al Moutaery, and M. Tariq Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats Behav. Brain Res. 153 2004 15 20 (Pubitemid 38829284)
2. M. Arshaduddin, S. Kadasah, S. Al Deeb, K. Al Moutaery, and M. Tariq Exacerbation of harmaline-induced tremor by imipramine Pharmacol. Biochem. Behav. 81 2005 9 14 (Pubitemid 40718947)
3. 14C]2- deoxyglucose in cat Exp. Brain Res. 42 1981 371 382 (Pubitemid 11112366)
4. A.J. Beitz, and D. Saxon Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway J. Neurocytol. 33 2004 49 74 (Pubitemid 38860219)
5. G.A. Bishop, and R.H. Ho The distribution and origin of serotonin immunoreactivity in the rat cerebellum Brain Res. 331 1985 195 207 (Pubitemid 15115329)
6. H. Braak, E Ghebremedhin, U. Rüb, H. Bratzke, and K. Del Tredec Stages in the development of Parkinson's disease-related pathology Cell Tissue Res. 318 2004 121 134 (Pubitemid 39362633)
7. M. Buonamici, R. Maj, F. Pagani, A.C. Rossi, and N. Khazan Tremor at rest episodes in unilaterally 6-OHDA-induced substantia nigra lesioned rats: EEG-EMG and behavior Neuropharmacology 25 1986 323 325 (Pubitemid 16165432)
8. M.A. Cenci, I.Q. Whishaw, and T. Schallert Animal models of neurological deficits: how relevant is the rat? Nat. Rev. Neurosci. 3 2002 574 579 (Pubitemid 135706667)
9. P. Damier, E.C. Hirsch, Y. Agid, and A.M. Graybiel The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease Brain 122 1999 1437 1448 (Pubitemid 29374122)
10. M.-P. Deiber, P. Pollak, R. Passingham, P. Landais, C. Gervason, L. Cinotti, K. Friston, R. Frackowiak, F. Mauguière, and A.L. Benabid Thalamic stimulation and suppression of parkinsonian tremor Brain 116 1993 267 279
11. Deuschl, G., Raethjen, J., Baron, R., Lindemann, M., Wilms, H., Krack, P., 2000. The pathophysiology of parkinsonian tremor: a review. J. Neurol. 247, Suppl. 5, v/33-48.
12. S. Dieudonné Serotonergic neuromodulation in the cerebellar cortex: cellular, synaptic, and molecular basis Neuroscientist 7 2001 207 219 (Pubitemid 32489115)
13. J.L. Eberling, P. Pivirotto, J. Bringas, and K.S. Bankiewicz Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys Exp. Neurol. 165 2000 342 346
14. P.S. Fishman Paradoxical aspects of parkinsonian tremor Mov. Dis. 23 2008 168 173 (Pubitemid 351311543)
15. M. Fukuda, A. Barnes, E.S. Simon, A. Holmes, V. Dhawan, N. Giladi, H. Fodstad, Y. Ma, and D. Eidelberg Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics NeuroImage 21 2004 608 615 (Pubitemid 38229923)
16. P. Heman, C. Barcia, A. Gómez, C.M. Ros, F. Ros-Bernal, J.E. Yuste, V. De Pablos, E. Fernandez-Villalba, M.R. Toledo-Cárdenas, and M.T. Herrero Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys Histol. Histopathol. 27 2012 89 94
17. Y. Ikai, M. Takada, Y. Shinionaga, and N. Mizuno Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei Neuroscience 51 1992 719 728
18. T. Ishibashi, J. Wakabayashi, and Y. Ohno 7-Hydroxy-N,N′-di-n- propyl-2-aminotetraline, a preferential dopamine D3 agonist, induces c-fos mRNA expression in the rat cerebellum Jpn. J. Pharmacol. 89 2002 309 315
19. K.A. Jellinger Post mortem studies in Parkinson's disease - is it possible to detect brain areas for specific symptom? J. Neural. Transm. Suppl. 56 1999 1 29
20. R. Kettler, M. Da Prada, and W.P. Burkard Comparison of monoamine oxidase - a inhibition by moclobemide in vitro and ex vivo in rats Acta Psychiatr. Scand. Suppl. 360 1990 101 102 (Pubitemid 20320312)
21. Y.S. Kim, J.H. Shin, F.S. Hall, and D.J. Linden Dopamine signaling is required for depolarization-induced slow current in cerebellar Purkinje cells J. Neurosci. 29 2009 8530 8538
22. J.S. Kizer, M. Palkovits, and M.J. Brownstein The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigral-hypothalamic-median eminence dopaminergic pathway Brain Res. 108 1976 363 370
23. W. Kolasiewicz, K. Kuter, J. Wardas, and K. Ossowska Role of the metabotropic glutamate receptor subtype 1 in the harmaline-induced tremor in rats J. Neural. Transm. 116 2009 1059 1063
24. W. Kolasiewicz, K. Kuter, P. Nowak, A. Pastuszka, and K. Ossowska Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats Cerebellum 10 2011 267 280
25. K. Kuter, M. Śmiałowska, J. Wierońska, B. Ziȩba, J. Wardas, M. Pietraszek, P. Nowak, I. Biedka, W. Roczniak, J. Konieczny, S. Wolfarth, and K. Ossowska Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats Brain Res. 1155 2007 196 207 (Pubitemid 46891437)
26. K. Kuter, W. Kolasiewicz, K. Gołembiowska, A. Dziubina, G. Schulze, K. Berghauzen, J. Wardas, and K. Ossowska Partial lesion of the dopaminergic innervation of the ventral striatum induces depressive-like behavior of rats Pharmacol. Rep. 63 2011 1383 1392
27. Y. Lamarre, C. De Montigny, M. Dumont, and M. Weiss Harmaline-induced rhythmic activity of cerebellar and lower brain stem neurons Brain Res. 32 1971 246 250
28. M.M. Lewis, G. Du, S. Sen, A. Kawaguchi, Y. Truong, S. Lee, R.B. Mailman, and X. Huang Differential involvement of striato- and cerebello-thalamo- cortical pathways in tremor-and akinetic/rigid-predominant Parkinson's disease Neuroscience 177 2011 230 239
29. E.D. Louis, G. Levy, L.J. Côte, H. Mejia, S. Fahn, and K. Marden Clinical correlates of action tremor in Parkinson's disease Arch. Neurol. 58 2001 1630 1634 (Pubitemid 32963227)
30. S.T. Mason, and H.C. Fibiger Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase J. Comp. Neurol. 187 1979 703 724 (Pubitemid 10227020)
31. J.H. McAuley, and C.D. Marsden Physiological and pathological tremors and rhytmic central motor control Brain 123 2000 1545 1567 (Pubitemid 30481180)
32. H. Mehta, K.S. Saravanan, and K.P. Mohanakumar Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice Behav. Brain Res. 145 2003 31 36 (Pubitemid 37188630)
33. C.A. Mejías-Aponte, C. Drouin, and G. Aston-Jones Adrenergic and noradrenergic innervation of the midbrain central tegmental area and retrorubral field; prominent inputs from medullary homeostatic center J. Neurosci. 29 2009 3613 3626
34. D.S. Melchitzky, and D.A. Lewis Tyrosine hydroxylase- and dopamine transporter-immunoreactivity axons in the primate cerebellum. Evidence for a lobular- and laminar-specific dopamine innervation Neuropsychopharmacology 22 2000 466 472 (Pubitemid 30145614)
35. T.E. Milner, G. Cadoret, L. Lessard, and A.M. Smith EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive J. Neurophysiol. 73 1995 2568 2577
36. H Miwa Rodent models of tremor Cerebellum 6 2007 66 72 (Pubitemid 46410668)
37. J.H. Miwa, K. Nishi, T. Fuwa, and Y. Mizuno Differential expression of c-Fos following administration of two tremorgenic agents: harmaline and oxotremorine NeuroReport 11 2000 2385 2390 (Pubitemid 30622276)
38. J. Mure, S. Hirano, C.C. Tang, I.U. Isaias, A. Antonini, Y. Ma, V. Dhavan, and D. Eidelberg Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects NeuroImage 54 2011 1244 1253
39. N.T. Panagopoulos, G.C Panagopoulos, and N.A. Matsokis Dopaminergic innervation and binding in the rat cerebellum Neurosci. Lett. 130 1991 208 212
40. G. Paxinos, and C. Watson The rat brain sixth ed. 2007 Elsevier Amsterdam
41. L.J. Poirier, T.L. Sourkes, G. Bouvier, R. Boucher, and S. Carabin Striatal amines experimental tremor and the effect of harmaline in the monkeys Brain 89 1966 37 52
42. P. Riederer, and J. Sian-Hülsmann The significance of neuronal lateralisation in Parkinson's disease J. Neural. Transm. 2012 10.1007/s00702-012-0775-1
43. A.-S. Rolland, M.-T. Herrero, V. Garcia-Martinez, M. Ruberg, E.C. Hisch, and C. Francois Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism Brain 130 2007 265 275 (Pubitemid 46026241)
44. E.R. Samuels, and E. Szabadi Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organization Curr. Neuropharmacol. 6 2008 235 253
45. B. Sjölund, A. Björklund, and J. Wiklund The indoleaminergic innervations of the inferior olive. 2. Relation to harmaline induced tremor Brain Res. 131 1977 23 27
46. J.C. Strahlendorf, H.K. Strahlendorf, and M. Lee Enhancement of cerebellar Purkinje cell complex discharge activity by microiontophoretic serotonin Exp. Brain Res. 1986 61 1986 614 624 (Pubitemid 16125760)
47. L. Timmermann, J. Gross, M. Dirks, J. Volkmann, H.-J. Freund, and A. Schnitzler The cerebral oscillatory network of parkinsonian resting tremor Brain 126 2003 199 212 (Pubitemid 36068570)
48. G. Wang, and S.C. Fowler Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine Psychopharmacology 158 2001 273 280 (Pubitemid 33071165)
49. M. Yamazaki, C. Tanaka, and S. Takaori Significance of central noradrenergic system on harmaline-induced tremor Pharmacol. Biochem. Behav. 10 1979 421 427 (Pubitemid 9188092)
50. J Yang, T.R. Sadler, T.K. Givrad, J.-M Maarek, and D.P. Holschneider Changes in brain functional activation during resting and locomotor states after unilateral damage in rats NeuroImage 36 2007 755 773 (Pubitemid 46907632)
51. H. Yu, D. Sternad, D.M. Corcos, and D.E. Vaillancourt Role of hyperactive cerebellum and motor cortex in Parkinson's disease NeuroImage 35 2007 222 233 (Pubitemid 46240941)